Evidence map›Paper›PMID 37986006›Full record

ArticleMolecular brain2023

Attenuation of estrogen and its receptors in the post-menopausal stage exacerbates dyslipidemia and leads to cognitive impairment.

Qinghai Meng, Ying Chao, Shurui Zhang, Xue Ding, Han Feng, Chenyan Zhang, Bowen Liu, Weijie Zhu, Yu Li, Qichun Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular brain, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Lifespan of male and female APP/PS1 and APPJournal of Alzheimer's disease : JAD · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Estrogen Receptors: A New Frontier in Alzheimer's Disease Therapy.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Qinghai Meng *School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Ying Chao *School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Shurui ZhangSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Xue DingSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Han FengSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Chenyan ZhangSchool of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Bowen LiuSchool of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Weijie ZhuSchool of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Yu LiSchool of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Qichun ZhangSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Huangjin TongDepartment of Pharmacy, Jiangsu Province Hospital of Integrated of Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.
Lixing WuDepartment of Cardiovascular, Jiangsu Province Hospital of Integrated of Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China. wulixing@jsatcm.com.
Huimin BianSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. 320561@njucm.edu.cn.
Nanjing University of Chinese Medicine · CNJiangsu Province Hospital · CN

Funding

National Natural Science Foundation of China 82204382National Natural Science Foundation of China 82274243National Natural Science Foundation of China 82374262National Natural Science Foundation of Nanjing University of Chinese Medicine XPT82204382Natural Science Research of Jiangsu Higher Education Institutions of China 22KJB310005
6 · The paper itself

Abstract

Cognitive dysfunction increases as menopause progresses. We previously found that estrogen receptors (ERs) contribute to dyslipidemia, but the specific relationship between ERs, dyslipidemia and cognitive dysfunction remains poorly understood. In the present study, we analyzed sequencing data from female hippocampus and normal breast aspirate samples from normal and Alzheimer's disease (AD) women, and the results suggest that abnormal ERs signaling is associated with dyslipidemia and cognitive dysfunction. We replicated a mouse model of dyslipidemia and postmenopausal status in LDLR

Indexed as

Cognitive DysfunctionEstrogen Receptor alphaAnimalsEstradiolEstrogen Receptor betaEstrogensFemaleHumansLipidsMicePostmenopauseSimvastatinEstradiolEstrogen Receptor alphaEstrogen Receptor betaEstrogensLipidsSimvastatinCognition impairmentDyslipidemiaEstradiolEstrogen receptorMenopause

Identifiers

PMID37986006
PMCPMC10662842
OpenAlexW4388835140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.